Data on enfortumab vedotin plus pembrolizumab for advanced bladder cancer, along with updates on antibody-drug conjugates, ...

Avelumab plus axitinib was effective and safe in real-world advanced kidney cancer, with outcomes matching clinical trials, according to AVION study findings.

The DeGregorio Family Foundation with support from the Torrey Coast Foundation Gastro Esophageal Investigator Network Initiative (GEMINI) has awarded the $125,000 to Timothy C. Wang, MD, Chief, ...

These curious molecules are both positively and negatively charged at the same time; the word “zwitter” in German means “hybrid” or “hermaphrodite”. Their unusual nature affords zwitterions a ...

Advanced Ovarian Cancer Pipeline Insights LAS VEGAS, NV, UNITED STATES, February 12, 2025 /EINPresswire / -- As per DelveInsight's assessme ...

(Reuters) -U.S. drugmaker Pfizer beat Wall Street estimates for fourth-quarter profit on Tuesday, helped by strong sales of its heart disease drug and a smaller-than-feared drop in COVID vaccine sales ...

Researchers identify a new player in human immunity that can go rogue and turn the immune system against the body’s own ...

NEW YORK, January 28, 2025--(BUSINESS WIRE)--Pfizer Inc. (NYSE ... the diverse needs of patients across various stages of disease." ...

Recently, Pfizer found itself in the agency's crosshairs thanks to one of its M&A plays. Now, Pfizer—which purchased neuroscience specialist Biohaven for $11.6 billion in 2022—is committing ...

Pfizer terminated partnership with Sangamo on hemophilia A gene therapy despite positive Phase 3 data. Find out why SGMO ...

The pharmaceutical giant Pfizer will pay nearly $60 million to resolve charges that a company it acquired paid kickbacks so that physicians would prescribe a specific migraine drug to patients ...

a sickle cell disease (“SCD”) therapy, serves as a cautionary tale. After paying >$5.5bn to acquire Global Blood Therpeutics and its lead commercial drug Oxbryta, Pfizer has had to withdraw ...